BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36796115)

  • 1. The Negative Impact of the New Coronavirus Pandemic on the Trend of Breast Biopsies and Their Direct Costs: Interrupted Time Series Analysis.
    Hyeda A; da Costa ÉSM; Kowalski SC
    Value Health Reg Issues; 2023 May; 35():8-12. PubMed ID: 36796115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The trend and direct costs of screening and chemotherapy treatment of breast cancer in the new coronavirus pandemic: total and interrupted time series study.
    Hyeda A; da Costa ÉSM; Kowalski SC
    BMC Health Serv Res; 2022 Dec; 22(1):1466. PubMed ID: 36461119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The New Coronavirus Pandemic and the Trend of Breast Cancer Diagnosis according to Age-Group: Total and Interrupted Time Series Study.
    Hyeda A; Costa ÉSMD; Kowalski SC
    Med Princ Pract; 2023; 32(2):117-125. PubMed ID: 36927744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Screening and BI-RADS Scoring Trends Before and During the COVID-19 Pandemic in an Academic Safety-Net Hospital.
    Kobzeva-Herzog A; O'Shea T; Young S; Kenzik K; Zhao X; Slanetz P; Phillips J; Merrill A; Cassidy MR
    Ann Surg Oncol; 2024 Apr; 31(4):2253-2260. PubMed ID: 38177460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice.
    Mendez A; Cabanillas F; Echenique M; Malekshamran K; Perez I; Ramos E
    Cancer; 2004 Feb; 100(4):710-4. PubMed ID: 14770425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted Time Series Analysis.
    Duarte MBO; Argenton JLP; Carvalheira JBC
    JCO Glob Oncol; 2022 Jun; 8():e2100371. PubMed ID: 35696624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammography in asymptomatic women aged 40-49 years.
    Silva FX; Katz L; Souza AS; Amorim MM
    Rev Saude Publica; 2014 Dec; 48(6):931-9. PubMed ID: 26039396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of probably benign (BI-RADS 3) lesions in mammography: what is the right follow-up protocol?
    Buch KA; Qureshi MM; Carpentier B; Cunningham DA; Stone M; Jaffe C; Quinn M; Gonzalez C; LaVoye J; Hines N; Bloch BN
    Breast J; 2015; 21(2):168-74. PubMed ID: 25669425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linked claims and medical records for cancer case management : evaluation of mammography abnormalities.
    Eberl MM; Watroba N; Reinhardt M; Pomerantz J; Serghany J; Broffman G; Fox CH; Mahoney MC; Edge SB
    Cancer; 2007 Aug; 110(3):518-24. PubMed ID: 17577210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB).
    Mendez A; Cabanillas F; Echenique M; Malekshamran K; Perez I; Ramos E
    Ann Oncol; 2004 Mar; 15(3):450-4. PubMed ID: 14998847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stereotactic Mammotome breast biopsy: routine clinical experience and correlation with BI-RADS--classification and histopathology].
    Michel SC; Löw R; Singer G; Otto R; Hohl M; Kubik RA
    Praxis (Bern 1994); 2007 Sep; 96(39):1459-74. PubMed ID: 17966279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neddle-guided biopsy in the diagnosis of non-palpable breast cancer].
    Becerra-Alcántara GI; Círigo-Villagómez LL; Ramos-Medina F; Robledo-Martínez H; Mar-Merinos CG; Panzi-Altamirano RM
    Ginecol Obstet Mex; 2015 Jul; 83(7):400-7. PubMed ID: 26422910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer risk prediction and mammography biopsy decisions: a model-based study.
    Armstrong K; Handorf EA; Chen J; Bristol Demeter MN
    Am J Prev Med; 2013 Jan; 44(1):15-22. PubMed ID: 23253645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Imaging Reporting and Data System (BI-RADS) breast composition descriptors: automated measurement development for full field digital mammography.
    Fowler EE; Sellers TA; Lu B; Heine JJ
    Med Phys; 2013 Nov; 40(11):113502. PubMed ID: 24320473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive predictive value of BI-RADS categorization in an Asian population.
    Tan YY; Wee SB; Tan MP; Chong BK
    Asian J Surg; 2004 Jul; 27(3):186-91. PubMed ID: 15564158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reported mammographic density: film-screen versus digital acquisition.
    Harvey JA; Gard CC; Miglioretti DL; Yankaskas BC; Kerlikowske K; Buist DS; Geller BA; Onega TL;
    Radiology; 2013 Mar; 266(3):752-8. PubMed ID: 23249570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms.
    Lehman C; Holt S; Peacock S; White E; Urban N
    AJR Am J Roentgenol; 2002 Jul; 179(1):15-20. PubMed ID: 12076896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter- and intraradiologist variability in the BI-RADS assessment and breast density categories for screening mammograms.
    Redondo A; Comas M; Macià F; Ferrer F; Murta-Nascimento C; Maristany MT; Molins E; Sala M; Castells X
    Br J Radiol; 2012 Nov; 85(1019):1465-70. PubMed ID: 22993385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.
    Berg WA; Berg JM; Sickles EA; Burnside ES; Zuley ML; Rosenberg RD; Lee CS
    Radiology; 2020 Jul; 296(1):32-41. PubMed ID: 32427557
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.